Transcatheter Aortic Valve Implantation: A Canadian Cardiovascular Society Position Statement John Webb, MD, FRCPC, Josep Rodés-Cabau, MD, FRCPC, Stephen.

Slides:

Advertisements

Similar presentations

Sex- and Gender-Related Risk Factor Burden in Patients With Premature Acute Coronary Syndrome Jin Choi, MSc, Stella Styliani Daskalopoulou, MD, MSc, PhD,

Advertisements

Canadian Journal of Cardiology

EARLY HEMODYNAMIC RESULTS IN PATIENTS WITH SMALL AORTIC ANNULUS UNDERGOING SURGICAL SUTURELESS AORTIC VALVE REPLACEMENT (PERCEVAL) AND BALLOON-EXPANDABLE.

Rationale and design of the Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure (TAVR UNLOAD)

Kiran Sidhu, MD, FRCPC, Anthony Tang, MD, FRCPC

A Meta-Analysis of Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement Hisato Takagi, MD, PhD, Masao Niwa, MD, Yusuke Mizuno,

Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.

Of mice and men and surgical transcatheter aortic valve insertion

Early effects of transcatheter aortic valve implantation and aortic valve replacement on myocardial function and aortic valve hemodynamics: Insights from.

Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters Victor Dayan, MD, PhD, Philippe Pibarot,

The Demise of Morphine Oxygen Nitroglycerin Aspirin (MONA)

582 Change in myocardial oxygenation during mild hypo- and hypercapnia: A blood oxygen level dependent cardiovascular magnetic resonance (BOLD-CMR) study.

Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD

Valve-in-valve transcatheter aortic valve implantation for failing surgical aortic stentless bioprosthetic valves: A single-center experience Alison.

Lars G. Svensson, MD, PhD, Eugene H. Blackstone, MD

Reply The Annals of Thoracic Surgery

Sandra Lauck, RN, PhD, Dion Stub, MD, PhD, John Webb, MD

A comprehensive review of the PARTNER trial

Characterization and outcome of patients with severe symptomatic aortic stenosis referred for percutaneous aortic valve replacement Samir R. Kapadia,

A Cardiac Myxoma With Intense Metabolic Activity

Robot-assisted real-time magnetic resonance image–guided transcatheter aortic valve replacement Justin G. Miller, MD, Ming Li, PhD, Dumitru Mazilu, PhD,

Transatlantic editorial on transcatheter aortic valve replacement

Allison L. Ruff, MD, Kathryn Teng, MD, Bo Hu, PhD, Michael B

Transapical transcatheter aortic valve-in-valve implantation: Clinical and hemodynamic outcomes beyond 2 years Jian Ye, MD, FRCSC, John G. Webb, MD,

John M. Fallon, MD, Joseph P. DeSimone, MD, J

Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: Changes in risks, valve types, and outcomes in the Society.

ACR Select Identifies Inappropriate Underutilization of Magnetic Resonance Imaging in British Columbia Kathleen Eddy, MD, Adam Beaton, MA, Richard Eddy,

Nat. Rev. Cardiol. doi: /nrcardio

Management of High-Risk Patients With Aortic Stenosis and Coronary Artery Disease Daniel Wendt, MD, Philipp Kahlert, MD, Tim Lenze, Markus Neuhäuser,

Management of small aortic annulus in the era of sutureless valves: A comparative study among different biological options Aly Ghoneim, MD, Ismail Bouhout,

Spontaneous Coronary Artery Dissection and Fibromuscular Dysplasia

Todd R. Vogel, MD, MPH, Viktor Y. Dombrovskiy, MD, PhD, MPH, Paul B

Suggested pathway for assessment of aortic valve replacement dysfunction. Suggested pathway for assessment of aortic valve replacement dysfunction. Transthoracic.

Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients.

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD

Long-term evaluation of biological versus mechanical prosthesis use at reoperative aortic valve replacement Vincent Chan, MD, MPH, B-Khanh Lam, MD, MPH,

Transapical transcatheter aortic valve implantation: 1-year outcome in 26 patients Jian Ye, MD, Anson Cheung, MD, Samuel V. Lichtenstein, MD, PhD, Lukas.

Transcatheter aortic valve replacement in intermediate-risk patients

Aortic Valve Bypass for the High-Risk Patient With Aortic Stenosis

Michele Gallo, MD, Gino Gerosa, MD

Early effects of transcatheter aortic valve implantation and aortic valve replacement on myocardial function and aortic valve hemodynamics: Insights from.

The aortic valve–sparing operation

Successful combined procedure of HeartMate II left ventricular assist device implantation and minimally invasive transapical aortic valve replacement

Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,

Commentary: Transaortic transcatheter aortic valve implantation: A route to be protected and not neglected Francesco Formica, MD, Gurmeet Singh, MD,

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

A derived and validated score to predict prolonged mechanical ventilation in patients undergoing cardiac surgery Vivek Sharma, MD, FRCA, Vivek Rao, MD,

Conventional redo biological valve replacement over 20 years: Surgical benchmarks should guide patient selection for transcatheter valve-in-valve therapy

Replicating the success of mitral valve repair in the aortic valve

Commentary: Bioprosthetic aortic valve replacement: A high standard of comparison for transcatheter aortic valve implantation Aaron Martin, MD, Michael.

Outcome of Patients With Aortic Stenosis Referred to a Multidisciplinary Meeting for Transcatheter Valve Marjan Jahangiri, FRCS, Jean Claude Laborde,

Sutureless replacement versus transcatheter valve implantation in aortic valve stenosis: A propensity-matched analysis of 2 strategies in high-risk patients

From Primary to Secondary Percutaneous Coronary Intervention: The Emerging Concept of Early Mechanical Reperfusion With Delayed Facilitated Stenting—When.

In pregnancy, aortic tissue is the issue

HUMAN EPIDIDYMIS PROTEIN 4 (HE4) IS ASSOCIATED WITH OUTCOME IN LOW- FLOW, LOW-GRADIENT AORTIC STENOSIS R. Abu-Alhayja'a, A. Dahou, M. Clavel, K. Aldahoun,

Permanent pacemaker insertion following transcatheter aortic valve replacement: Not infrequent, not benign, and becoming predictable Craig M. Jarrett,

Commentary: When a choice is not an echo

To pleat or not to pleat…is that the question?

408 Can a single VO2max test induce reversible myocardial injury in healthy endurance trained men? insights from T2-weighted cardiovascular magnetic resonance.

Vinay Badhwar, MD, John S. Ikonomidis, MD, PhD, Jeffrey P. Jacobs, MD

Racing to the Rubicon Michael J. Reardon, MD, Vinod H. Thourani, MD

Mobile Medicine: Digital Dynamo or Virtual Vaporware

National trends in utilization and in-hospital outcomes of mechanical versus bioprosthetic aortic valve replacements Abby J. Isaacs, MS, Jeffrey Shuhaiber,

Lessons from the first patient to undergo full aortic root replacement using a homograft: A 29-year follow-up Sajiram Sarvananthan, MBBS, Giovanni Melina,

Cardiac magnetic resonance imaging is more diagnostic than 2-dimensional echocardiography in determining the presence of bicuspid aortic valve S. Chris.

Transcatheter aortic valve implantation versus surgical aortic valve replacement: A propensity score analysis in patients at high surgical risk Lenard.

Thanos Sioris, MD, Tirone E

Paul Philipp Heinisch, MD, Thierry Carrel, MD

Spontaneous Coronary Artery Dissection

Presentation transcript:

Transcatheter Aortic Valve Implantation: A Canadian Cardiovascular Society Position Statement John Webb, MD, FRCPC, Josep Rodés-Cabau, MD, FRCPC, Stephen Fremes, MD, FRCSC, Philippe Pibarot, DVM, PhD, Marc Ruel, MD, FRCSC, Reda Ibrahim, MD, FRCPC, Robert Welsh, MD, FRCPC, Christopher Feindel, MD, FRCSC, Samuel Lichtenstein, MD, FRCSC Canadian Journal of Cardiology Volume 28, Issue 5, Pages 520-528 (September 2012) DOI: 10.1016/j.cjca.2012.04.015 Copyright © 2012 Canadian Cardiovascular Society Terms and Conditions

Figure 1 The spectrum of surgical risk. Transcatheter aortic valve implantation (TAVI) has been shown to be a viable alternative to surgery in patients who are at high or extreme risk with conventional surgery due to advanced age or comorbidities. These patients represent the highest risk; 5% to 10% of patients with severe aortic stenosis. TAVI has not yet been directly compared with surgery in the majority of patients who would be predicted to be at low or intermediate surgical risk. PARTNER, Placement of Aortic Transcatheter Valves; SURTAVI, Surgical Replacement and Transcatheter Aortic Valve Implantation. Canadian Journal of Cardiology 2012 28, 520-528DOI: (10.1016/j.cjca.2012.04.015) Copyright © 2012 Canadian Cardiovascular Society Terms and Conditions

Figure 2 Clinical decision tree for patients with aortic stenosis. AVR, aortic valve replacement; TAVI, transcatheter aortic valve implantation. Canadian Journal of Cardiology 2012 28, 520-528DOI: (10.1016/j.cjca.2012.04.015) Copyright © 2012 Canadian Cardiovascular Society Terms and Conditions

Figure 3 Evaluation of patients being considered for transcatheter aortic valve implantation (TAVI). AS, aortic stenosis; AVR, aortic valve replacement; CT, computed tomography; MRI, magnetic resonance imaging; MSCT, multislice computed tomography; PTCA, percutaneous transluminal coronary angioplasty; TTE, transthoracic echocardiography. Canadian Journal of Cardiology 2012 28, 520-528DOI: (10.1016/j.cjca.2012.04.015) Copyright © 2012 Canadian Cardiovascular Society Terms and Conditions